Dr. Marcelo Dietrich's lab at Yale University studies how the early interactions between mothers and infants shape brain development and social behavior. They focus on understanding specific neuron types that influence these interactions and the impacts of early life adversity, like childhood maltreatment, on long-term mental health. By investigating these neural systems in mice, the lab aims to uncover insights that could enhance developmental outcomes and help address social and psychological disorders.

Dr. James S. Duncan's lab at Yale University focuses on improving treatments for autism spectrum disorder (ASD) and liver cancer using advanced imaging techniques and machine learning. For autism, the team aims to develop deep learning models that can identify brain biomarkers and predict treatment outcomes. In liver cancer, they explore innovative imaging methods to characterize tumor environments and improve patient care through personalized treatment strategies based on non-invasive biomarkers.

Alvaro Duque's lab at Yale focuses on studying the macaque brain, which is closely related to human brains, to understand brain development, function, and disease better. They maintain a unique collection of brain tissues from macaques that ranges from embryos to adults, allowing researchers to study various aspects of neuroscience without having to use more animals in experiments. This resource aims to promote research while ensuring ethical practices in animal studies.

Dr. Kathryn M Ferguson's lab at Yale University focuses on understanding how the environment of cells, specifically the membranes they are part of, affects the behavior and structure of integral membrane proteins (IMPs). This research is critical because many drugs target these proteins, but we often don't fully understand how they work. By using innovative technologies and interdisciplinary collaboration, the lab aims to reveal how these proteins function and interact with their surrounding membranes.

Dr. Jorge E. Galan's research lab at Yale University focuses on understanding how the bacterium Salmonella affects host cells. By studying the ways that Salmonella uses specific proteins to manipulate cellular functions, the lab aims to uncover the secrets of how the bacteria survive and cause disease. This research could lead to new treatments and preventions for Salmonella infections, which pose a significant public health threat. The team investigates cellular signaling pathways and immune responses to advance our knowledge of host-pathogen interactions.

Dr. Antonio J. Giraldez's lab at Yale University focuses on understanding how the structure of the genome influences gene expression during early development, particularly in zebrafish. They investigate the mechanisms that allow gene regulatory elements, like enhancers and promoters, to communicate effectively, which is crucial for proper embryonic development. The lab employs innovative techniques such as expansion microscopy to visualize chromatin organization and to decode genetic variations that affect gene function.

Andrew L Goodman's lab at Yale University studies the complex interactions between our gut microbiome and the food we eat. They focus on how different diets influence microbial communities in our intestines and how these microbes, in turn, affect our health, specifically in relation to food-borne infections. By understanding these interactions, the lab aims to find ways to improve health outcomes and fight infections caused by pathogens like Salmonella and Campylobacter.

Dr. Ira M Hall's lab at Yale University focuses on understanding the genetic basis of complex diseases, particularly coronary artery disease. They develop advanced methods for analyzing whole genome sequencing data, aiming to improve gene mapping studies by using a diverse set of reference genomes. By leveraging these cutting-edge techniques, the lab seeks to uncover new genetic variants that contribute to disease risk across various populations.

Dr. Michelle Hampson's lab at Yale University focuses on innovative treatments for adolescents with Tourette Syndrome using neurofeedback techniques. Their current research is a clinical trial that helps participants learn to control specific areas of their brain to reduce tic severity through targeted mental strategies. The lab aims to confirm the effectiveness of this intervention and analyze its impact on brain connectivity and behavior.

Dr. Stavroula Hatzios's lab at Yale University conducts research on how microbial infections contribute to cancer development. By focusing on oxidative stress, which is often caused by infections, they study how specific sites on proteins are modified and impact cellular functions. The lab utilizes innovative techniques to uncover these modifications, aiming to establish new therapeutic strategies to combat cancer linked to infections.

Dr. Shangqin Guo's lab focuses on understanding how certain proteins, known as linker histones, can influence the development of blood cells from their precursor cells. The research investigates how manipulating these proteins could lead to better outcomes in diseases like cancer and blood disorders by promoting the production of immune cells. The lab uses a variety of genetic models and inhibitors to explore these mechanisms at a molecular level, aiming to create new therapeutic strategies for treating hematological diseases.

Dr. Joao Pereira's research lab at Yale University focuses on understanding how blood cells, particularly immune cells, develop from stem cells in the bone marrow. The lab investigates the complex signaling mechanisms that regulate the balance between cell dormancy and activity, which are crucial for maintaining a healthy immune system. Through a combination of advanced molecular techniques and imaging methods, the team's work aims to uncover new insights into immune disorders and potential therapeutic targets for diseases like cancer.

Dr. Diane Krause's lab at Yale University focuses on understanding how specific blood cell types, like platelets and red blood cells, are formed from stem cells in the bone marrow. By studying a transcription factor called RUNX1, which is commonly mutated in leukemia, the lab aims to uncover the molecular mechanisms that dictate whether a cell becomes a platelet or a red blood cell. This research has important implications for developing new treatments for blood-related diseases.

Dr. Richard Flavell's lab at Yale University focuses on studying Alcoholic Liver Disease (ALD), particularly Alcohol Associated Hepatitis (AAH), using advanced humanized mouse models. These models mimic human liver conditions better than traditional mouse models, allowing researchers to explore cellular interactions and metabolic changes in the liver that contribute to disease. The lab aims to uncover how specific signaling interactions between liver cells and immune cells are involved in AAH to identify potential treatment targets.

The Xiong laboratory at Yale University focuses on understanding the life cycle of HIV-1, particularly how the virus matures and enters the nucleus of host cells. By using advanced imaging techniques like cryo-electron microscopy, the lab investigates the structural changes that occur during the maturation of the HIV-1 capsid and how this process can be inhibited by certain drugs. Their research aims to advance our understanding of HIV-1 biology and contribute to the development of new anti-HIV therapies.

Dr. Ya-Chi Ho's lab at Yale University focuses on understanding how HIV-1 persists in the immune system, specifically in CD4+ T cells, which are critical for immune defense. Despite treatment, HIV-1 infected cells can survive and even proliferate, making it difficult to completely eliminate the virus. The lab uses advanced single-cell technologies to investigate the mechanisms behind HIV-1 persistence and how these infected cells evade immune responses, aiming to identify better therapeutic targets for HIV treatments.

Dr. Karen S. Anderson's lab at Yale University focuses on developing new treatments for HIV, particularly in designing and optimizing drugs that target HIV reverse transcriptase, an essential enzyme in the HIV life cycle. The lab combines computational methods with experimental studies to develop novel anti-HIV medications that are effective against drug-resistant strains and reduce the HIV reservoirs in patients. By creating long-acting and combination therapies, they aim to improve patient compliance and overall treatment outcomes for those living with HIV.

Scott Holley's lab at Yale University studies how the body of zebrafish develops, focusing on understanding the early stages of spinal column formation. Using zebrafish as a model organism, the research explores the mechanisms behind human developmental issues, such as scoliosis and spina bifida. The lab combines various techniques like genetics and live imaging to uncover how cells interact and organize during development, contributing to a more profound understanding of biological order and developmental stability.

The DiMaio lab at Yale University studies how human papillomavirus (HPV) enters human cells and contributes to cancer. By understanding the mechanisms behind HPV infection, including viral proteins and their interactions within the host cell, the lab aims to find new ways to prevent and treat HPV-related diseases. Their groundbreaking research explores the role of specific proteins in HPV entry and seeks to design new therapies based on their findings.

Dr. Yiyun Henry Huang's lab at Yale University focuses on understanding and diagnosing Alzheimer's disease using advanced imaging techniques. The lab is particularly interested in the sigma-1 receptor, which plays a crucial role in the disease's progression. By developing new PET imaging agents, the lab aims to uncover important biomarkers that could lead to earlier diagnosis and better monitoring of disease treatments.